PharmaReports: Pipeline analysis and market research reports
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery and categorized into relevant areas. Browse the area meeting your field of interest or try our search engine.
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development
Focus on Oncology: All reports focusing on oncology are featured here with the exception of antibody, immunological or cell therapeutic approaches which are listed on the Cancer Immunotherapy channel.
- Protein Therapeutics Markets: Antithrombins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines
- Bone Metastases - Current Therapeutic Options, Unmet Needs and Pipeline Candidates
- Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer
- Molecular Targeted Cancer Therapies - More drugs on the market, more targets in the pipeline
- Supportive Care in Cancer Treatment - Some first-generation products proving difficult to dislodge
- Pipeline Insight: Hematological Malignancies - Pursuit for the next blockbuster intensifies
- Stakeholder Insight: Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged
- Pipeline Insight: Innovative therapies - Targeted therapy, a clinical and commercial revolution?
- Targeted Cancer Therapies: Innovative drugs and their impact on the future of oncology
- Pipeline Insight: Breast Cancer - Complex Combinations of Old and New?
Focus on Cancer Immunotherapy: This channel is dedicated to immunotherapy approaches to cancer such as interleukins and other immunostimulators. Oncolytic viruses and cell based therapies are also included in this channel. Most reports included in this channel are technological in approach.
- Top-10 Biotech Companies - Market Outlook, 2008-2023
- Pipeline Insight: Breast Cancer - Targeted Therapies, New Cytotoxics and Vaccines
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- KIDNEY CANCER - Therapy Area Pipeline Report
- Immunotherapy in Oncology: Gaining Momentum
- Colorectal Cancer Drug Pipeline Update 2007
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Pipeline Insight: Hematological malignancies - Targeted treatments & immunotherapy
Focus on Immunology & Inflammatory Diseases: Reports relating to inflammatory diseases and organ transplant are featured in this channel. Articles on osteoarthritis are also featured here. Reports focusing on immunological approaches to other disease states can also be included in this channel.
- Commercial Insight: Asthma/COPD - ICS/LABA combinations continue to dominate
- Asthma and COPD - Get SMART
- Pipeline Insight: Asthma/COPD - Targeted therapies on the horizon
- Osteoarthritis - Market sees steady growth
- Commercial and Pipeline Insight: Allergic Rhinitis
- Respiratory Market Insight 2008
- AUTOIMMUNE DISEASES - Therapy Area Pipeline Report
- Disease Modifying Osteoarthritis Drugs - The Search for the Holy Grail Continues
- World OTC Pharmaceutical Markets
- Rheumatoid Arthritis: The 45+ Market in the United States for Drugs and Biologics
Focus on Infectious Diseases: Reports included here span all the major infectious diseases.
- The Indian Pharmaceutical Market Analysis and Forecasts
- Antibacterial Drug Market Analysis 2008-2013
- Commercial and Pipeline Insight: Hepatitis B
- STAPHYLOCOCCAL INFECTIONS - Therapy Area Pipeline Report
- The Global Anti-Infectives Market Outlook to 2011
- Pipeline Insight: HIV
- Respiratory Tract Infections in the USA
- Global Tuberculosis Strategies
- Vaccines: The World Market
- Mens Health: The Market for Current and Emerging Drug Therapies
Focus on Psychiatric, Addictive & Sleep Disorders: This channel focuses on the main psychiatric diseases such as depression, bipolar disease, anxiety and schizophrenia although reports focusing on neuroelectrophysiology (for example epilepsy) are also included here. Likewise reports relating to addictive, sleep and attention deficit disorders are also included here.
- Pipeline Insight: Substance Dependence - Alcohol
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia
- SMOKING CESSATION - Therapy Area Pipeline Report
- SCHIZOPHRENIA - Therapy Area Pipeline Report
- Cognitive Impairment in Schizoaffective Disorder
- Parkinson's Disease and Restless Legs Syndrome - Reformulations set to drive near-term growth
- The World Market for Antidepressants, 2006
- Stakeholder Insight: Bipolar Disorders - Zyprexa Sets the Mood for Revenue Growth
- Commercial Insight: Antidepressants - Sliding SSRI Revenues Inevitable
Focus on Pain: This channel focuses on the major pain etiologies. In addition reports relating to migraine and occasionally IBS will be found in this channel.
- DENTAL PAIN - Therapy Area Pipeline Report
- The osteoarthritis market - COX-2 inhibibitors, NSAIDs and corticosteroids
- Irritable Bowel Syndrome - A potentially profitable market with limited competition
- Osteoarthritis - The Wait for a DMOAD Continues
- Commercial Insight: Pain Market Overview - Non-traditional analgesics and opioid reformulations to sustain sector growth
- Neuronal Nicotinic Receptors - June 2008
- Endo Pharmaceuticals’ Lidoderm - Physician survey indicates increased use likely to fuel sales
- Neuropathic Pain Insight - Life Beyond Gabapentin
- UpdatesPlus-Nicotinic Receptors (February 2008)
- The World Market for Pain Management Drugs and Devices: Applications and Top Products
Focus on Neurodegenerative & Neuroelectrophysiological Disorders: This channel focusses on the chronic neurodegenerative disorders. Reports investigating memory/cognitive decline are also listed here unless they are clearly unrelated to neurodegeneration. In addition, reports relating to acute neurodegeneration such as stroke and cerebral hemorrhage can be included here.
- Alzheimer's Disease: Markets, Pipeline and Opportunities 2009
- Neuronal Nicotinic Receptors - July 2008
- SEIZURES - Therapy Area Pipeline Report
- EPILEPSY - Therapy Area Pipeline Report
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Parkinson's Disease - Review of Key Commercial Opportunities in the Symptomatic Treatment Market
- Alzheimer's Disease - Prescribing trends indicate that neurologists are not adhering to guidelines
- Neuroprotection - Drugs, Markets and Companies
- Commercial Perspectives: Multiple Sclerosis - How to Find Opportunities in an Unremitting Market
- Alzheimer's Disease - Diagnosis, Disease Modification and Prevention Key to Growing Market
Focus on Metabolic & Hormonal Disorders: Reports featured here primarily focus on diabetes and obesity. Cachexia is also a focus of this channel as is metabolic dysfunction relating to pharmacological treatment (for example following treatment for HIV infection). Reports relating to hormonal disorders or diseases due to hormonal change (eg osteoporosis) can be featured here.
- Obesity Drug Markets in the US and EU: Analysis of product pipelines and the competitive environment
- Women's Reproductive Disorders Therapeutics 2008-2018
- Drug Delivery Technology: Revolutionizing Diabetes Treatment
- Infertility - Therapy Area Pipeline Report
- DIABETIC NEUROPATHY - Therapy Area Pipeline Report
- Pipeline Insight: Osteoporosis - Intermittent dosing drives market growth
- The World Diabetes Market, 2005-2011
- Diabetes, Metabolic Syndrome and Cardiovascular Disease
- Diabetes and Diabetic Complications: Major World Markets
- Stakeholder Insight: Insulin Use in Type 2 Diabetes - From Last Resort to Early Intervention
Focus on Cardiovascular Disorders: Reports relating to all aspects of cardiovascular disease are included here with the exception of those relating to neurodegenerative components of stroke. Reports with a focus on atherosclerosis are also included here
- Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need
- Percutaneous Coronary Intervention
- Stakeholder Insight: Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture
- The Anti-Migraine Market 2007-2022
- ANGINA - Therapy Area Pipeline Report
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
- Chronic and Acute Heart Failure
- Pulmonary Arterial Hypertension - A small market gets big attention
- Pipeline Insight: Antihypertensives - Weak pipeline leaves innovation to Novartis
- Commercial Insight: Antithrombotics - Sanofi-Aventis the Dominant Player
Focus on GenitoUrinary Tract Disorders: Listed here are reports relating to sexual dysfunctions as well as urinary tract (urinary incontinence and BPH) and uterine disorders (eg endometriosis)
- Erectile Dysfunction Market Assessment & Analysis 2007-2022
- Commercial and Pipeline Insight: Infertility
- Female Sexual Dysfunction: Prescription Drug Pipeline Overview 2007
- Female Sexual Dysfunction - 2005 physician survey
- Mixed Urinary Incontinence - An Opportunity for Novel Drug Therapies
- Urinary Incontinence and Overactive Bladder - The Perspective of the Continence Nurse in the US
- Palatin Technologies' Bremelanotide - Competition and regulatory risk cloud potential
- Dry Overactive Bladder - A Precursor to 'Wet Overactive Bladder'?
- Interstitial Cystitis - Few Treatments, Poor Outcome
- The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being
Focus on Technology: The technology channel relates to all things biotech. Reports describing, for example, advances in peptide, protein, genomics/proteomics and cell based sciences are included. This channel also focuses on novel drug delivery technologies and novel screening tools
- Biotech Exit Strategies: Delivering value to investors in a challenging funding market
- Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors
- Stakeholder Opinions: Sarcomas
- Commercial Insight: Autoimmune Diseases - Market continues to prosper
- Organ Transplant Immunosuppressive Markets
- Decoding Big Pharmas R&D Strategy in Oncology
- ASTHMA - Therapy Area Pipeline Report
- Psoriasis - Anti-TNF's lead another indication
- Cell Therapy - Technologies, Markets and Companies
- The Outlook For RNAi: Accelerating drug discovery and the development of RNAi therapeutics
Focus on Diagnostics & Devices: This channel focuses on molecular diagnostics, primarily with an infectious disease, oncology or cardiovascular disease angle. Reports relating to devices primarily focus on cardiovascular devices including stents and pacemakers.
- Reusable Medical Devices and Instruments
- High-Tech Patient Monitoring Systems
- The World Market for Catheters
- Medical Imaging Markets, Volume V: Molecular Imaging
- Genomics World Markets
- Clinical Immunoanalyzer Markets
- Clinical Laboratory Testing Volume 1: Reagents and Instruments
- Point of Care Diagnostic Testing - World Markets
- Microarray Markets
- Point of Care Diagnostic Testing Sector Trends
- Technology Transfer Strategies: Maximizing the returns from new technologies
- The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008
- Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
- Titan Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials
- Telik Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials
- Pharmaceutical Pricing and Reimbursement: Strategies for market access
- Medicare Part D - Impact on US drug pricing issues & role as a driver towards European style pricing
- Stakeholder Opinions: Esophageal Cancer Treatment paradigms need revolution not evolution
- Product Lifecycle Management, 2006
- The U.S. Market for Private Label OTC Healthcare Products